Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063241) titled 'Barriers and Facilitators to Physical Activity Among Adult Women with Breast and Gynecologic Cancer Following Primary Treatment: A Scoping Review Using the COM-B Model' on Oct. 12.

Study Type: Observational

Primary Sponsor: Institute - Niigata College of Nursing

Condition: Condition - breast and gynecologic cancer (cervical cancer, endometrial cancer, ovarian cancer, etc.) Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - This scoping review aims to map existing evidence regarding barriers to and facilitators of physical activity among adult women with breast and gynecologic cancer following primary treatment. Although physical activity is recommended for cancer survivors, maintaining regular activity remains challenging due to various physical, psychological, and social factors. The review will synthesize evidence related to walking and low-intensity resistance training in home and community settings, and categorize identified barriers and facilitators using the COM-B (Capability, Opportunity, Motivation-Behavior) model.

Research question for this review: Established based on the Joanna Briggs Institute (JBI) PCC framework Adult women with breast and gynecologic cancer following primary treatment

Barriers and facilitators to the maintenance and promotion of walking and low-intensity resistance training

Home and community settings, with findings mapped onto the COM-B model Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old

Adult women survivors with breast cancer or gynecological cancer (e.g., cervical, endometrial, or ovarian cancer) following primary treatment: Patients receiving ongoing endocrine therapy are considered to be post-primary treatment.

Barriers and facilitators related to the maintenance and promotion of walking and low-intensity resistance training (40-60% of 1RM or less, or defined by the authors as low to moderate intensity)

Home and community settings: Studies that include facility visits for purposes such as initial instruction will be included, provided that home-based exercise is the primary component of the intervention and factors related to its continuation can be extracted. Key exclusion criteria - Based on the JBI PCC framework, the following exclusion criteria were established.

Participants: Children, adolescents only, men, other cancer types only, receiving palliative care, or in the terminal phase Proportion of target diseases: Less than 50% of the total participants have the target diseases Disease stage: Recurrent cancer, metastatic cancer, or Stage IV only

Physical activity and intensity: Exercises other than walking and low-intensity strength training (e.g., yoga, tai chi, swimming, high-intensity strength training) Duration of physical activity (intervention period): During primary treatment only

The primary setting of the exercise is outside the home (e.g., all exercises are conducted in hospitals, facilities, or rehabilitation centers; or exercises are performed 2-3 times a week at a facility with home exercises serving only as a supplement). Target Size - 0

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2026 Year 07 Month 06 Day Date of IRB - 2026 Year 07 Month 06 Day Anticipated trial start date - 2026 Year 08 Month 10 Day Last follow-up date - 2027 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072310

Disclaimer: Curated by HT Syndication.